Overview
Revocon 25 mg Tablets contain Tetrabenazine, a vesicular monoamine transporter 2 (VMAT2) inhibitor used in the treatment of movement disorders such as chorea associated with Huntington’s disease, and other hyperkinetic movement disorders including tardive dyskinesia and Tourette syndrome. It works by reducing the levels of certain chemicals in the brain that are involved in nerve and muscle control.





